Catalyst Wire Dossier Catalyst Wire Dossier

HIB210

· HI-Bio, A Biogen Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HIB210, covering 2025-02-07 to 2025-02-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Safety and Drug Levels of HIB210 in Healthy Volunteers [Phase 1]

See pricing